A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer

NCT04311034 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: RC48

Sponsor

RemeGen Co., Ltd.